Edition:
United Kingdom

Celldex Therapeutics Inc (CLDX.OQ)

CLDX.OQ on NASDAQ Stock Exchange Capital Market

0.26USD
7 Dec 2018
Change (% chg)

$-0.00 (-0.00%)
Prev Close
$0.26
Open
$0.28
Day's High
$0.28
Day's Low
$0.26
Volume
268,742
Avg. Vol
280,230
52-wk High
$3.08
52-wk Low
$0.26

Chart for

About

Celldex Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of several immunotherapy technologies for the treatment of cancer and other diseases. Its lead drug Rintega (also referred to as rindopepimut and CDX-110) is a therapeutic vaccine, which is meant for the... (more)

Overall

Beta: 2.67
Market Cap(Mil.): $405.56
Shares Outstanding(Mil.): 128.34
Dividend: --
Yield (%): --

Financials

  CLDX.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -1.10 -- --
ROI: -43.88 0.28 15.02
ROE: -53.51 0.94 16.60

BRIEF-Novartis Receives Health Canada Approval Of Its Car-T Cell Therapy, Kymriah I

* NOVARTIS RECEIVES HEALTH CANADA APPROVAL OF ITS CAR-T CELL THERAPY, KYMRIAH™ (TISAGENLECLEUCEL)I

06 Sep 2018

Earnings vs. Estimates